Rituximab for relapsing‐remitting multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source
twitter: 5 X users

facebook: 1 Facebook page
wikipedia: 6 Wikipedia pages

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 284 Mendeley

Summary Blogs Policy documents X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 blog post.

Verlaufsmodifizierende Therapien bei MS – Recap der Cochrane Evidenz

Wissen was wirkt, 28 Nov 2017

In diesem zweiten von drei Beiträgen zu Multipler Sklerose (MS) teilt die freiwillige Cochrane Übersetzerin Brita Fiess Fakten…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.